Cosponsor
Sign in

S 652 · in committee · significant

Protecting Patients from Deceptive Drug Ads Act

What this bill does

  • The bill penalizes false or misleading prescription drug ads on social media by influencers and healthcare providers.
  • Social media influencers, healthcare providers, telehealth platforms, and drug manufacturers are affected.
  • The FDA enforces civil penalties, issues guidance, and conducts market surveillance of drug promotions online.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

  1. 01

    How would the FDA distinguish between misleading drug claims and legitimate patient testimonials shared by influencers on social media?

  2. 02

    What enforcement resources and funding would the FDA need to monitor prescription drug advertisements across multiple social media platforms?

  3. 03

    Which groups—influencers, healthcare providers, or manufacturers—should bear primary responsibility for ensuring drug ads comply with FDA standards?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · D-IL

Richard J. Durbin

Citizen cosponsors

0

In Congress

1/ 100

Senators cosponsoring

Introduced 2025-02-20

Joining the bill

Legislative timeline

  1. 2025-02-20 · senate · IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S1129-1130)

  2. 2025-02-20 · IntroReferral

    Introduced in Senate

Congress.gov ↗

Citizen comments

Sign in to comment on this bill.

No comments yet — be the first.